Finance

Beta
Lists
2633:HKG
Jacobson Pharma Corporation Ltd
HK$1.04
0.00%
(0.00) 1D
Jun 30, 4:00:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2633...
Open
HK$1.05
High
HK$1.05
Low
HK$1.02
Mkt. cap
2.08B
Avg. vol.
317.61K
Volume
374.00K
Dividend
8.65%
Quarterly dividend
HK$0.02
Ex-dividend date
Sep 7, 2026
P/E ratio
6.89
52-wk high
HK$1.78
52-wk low
HK$0.98
EPS
HK$0.15
Shares outstanding
2.00B
No. of employees
2K
Open
HK$1.05
High
HK$1.05
Low
HK$1.02
Mkt. cap
2.08B
Avg. vol.
317.61K
Volume
374.00K
Dividend
8.65%
Quarterly dividend
HK$0.02
Ex-dividend date
Sep 7, 2026
P/E ratio
6.89
52-wk high
HK$1.78
52-wk low
HK$0.98
EPS
HK$0.15
Shares outstanding
2.00B
No. of employees
2K
News stories
From sources across the web
About Jacobson Pharma Corporation Ltd
CEO-
Employees1.77K
Founded2016
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in HKD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in HKD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
383.28M
383.28M
401.46M
401.46M
Cost of goods sold
214.38M
214.38M
231.40M
231.40M
Cost of revenue
214.38M
214.38M
231.40M
231.40M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
84.50M
84.50M
77.87M
77.87M
Operating expense
76.94M
76.94M
68.14M
68.14M
Total operating expenses
291.32M
291.32M
299.54M
299.54M
Operating income
91.96M
91.96M
101.91M
101.91M
Other non operating income
-
-
-
-
EBT including unusual items
86.77M
86.77M
94.55M
94.55M
EBT excluding unusual items
89.21M
89.21M
95.96M
95.96M
Income tax expense
15.75M
15.75M
14.76M
14.76M
Effective tax rate
18.15%
18.15%
15.61%
15.61%
Other operating expenses
-7.55M
-7.55M
-9.73M
-9.73M
Net income
71.02M
71.02M
79.79M
79.79M
Net profit margin
18.53%
18.53%
19.88%
19.88%
Earnings per share
-
-
-
-
Interest and investment income
2.25M
2.25M
1.91M
1.91M
Interest expense
-6.46M
-6.46M
-8.90M
-8.90M
Net interest expenses
-4.20M
-4.20M
-6.99M
-6.99M
Depreciation and amortization charges
-
-
-
-
EBITDA
122.05M
122.05M
132.01M
129.16M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more